Call Options

7 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.01 - $1.46 $5,252 - $7,592
-5,200 Reduced 22.61%
17,800 $22,000
Q2 2024

Aug 14, 2024

BUY
$1.26 - $1.66 $8,820 - $11,620
7,000 Added 43.75%
23,000 $30,000
Q1 2024

May 15, 2024

BUY
$1.25 - $2.71 $20,000 - $43,360
16,000 New
16,000 $21,000
Q3 2023

Nov 14, 2023

SELL
$3.07 - $6.2 $57,716 - $116,560
-18,800 Reduced 87.85%
2,600 $8,000
Q2 2023

Aug 14, 2023

BUY
$2.75 - $7.59 $40,700 - $112,332
14,800 Added 224.24%
21,400 $107,000
Q1 2023

May 15, 2023

BUY
$2.45 - $3.59 $8,330 - $12,206
3,400 Added 106.25%
6,600 $19,000
Q4 2022

Feb 14, 2023

BUY
$1.4 - $5.02 $4,480 - $16,063
3,200 New
3,200 $7,000

Others Institutions Holding APYX

About Apyx Medical Corp


  • Ticker APYX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,573,000
  • Market Cap $49.8M
  • Description
  • Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...
More about APYX
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.